Skip to main content
SpringerLink
Log in

The Changing Healthcare Environment

Socioeconomic Evaluation of Drug Therapy

  • Guest Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Di Masi JA, Hansen RW, Grabowski HG, Lasagna L. Cost of innovation in the pharmaceutical industry. Journal of Health Economics 10: 107–142, 1991

    Article  Google Scholar 

  • Dranlove D. The costs of compliance with the 1962 FDA amendments. Journal of Health Economics 10: 235–238, 1991

    Article  Google Scholar 

  • Drummond MF. Economic evaluation of Pharmaceuticals: science or marketing? PharmacoEconomics 1: 8–13, 1992

    Article  PubMed  CAS  Google Scholar 

  • Drummond MF, Teeling-Smith G, Wells N. Economic evaluation in the development of medicines, Office of Health Economics, London, 1988

    Google Scholar 

  • Editorial. Farewell to promoting goodbuys? Lancet 338: 416–417, 1991d

  • Editorial. Priceless medicines. Economist, 26 October: 14–15, 1991a

  • Editorial. Healthy results. Economist, 26 October: 85, 1991b

  • Editorial. Dangerous medicine. Economist, 9 November: 48, 1991c

  • Eddy DM. Oregon’s plan: should it be approved? Journal of the American Association 266: 2268–2271, 1991

    Article  Google Scholar 

  • Evans D, Freund D, Dittus R, Robertson J, Henry D. The use of economic analysis as a basis for inclusion of pharmaceutical products on the Pharmaceutical Benefits Scheme, Commonwealth Department of Community Services and Health, Canberra, 1990

    Google Scholar 

  • Henry D. Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for Pharmaceuticals. PharmacoEconomics 1(1): 55–68, 1992

    Article  Google Scholar 

  • Hillman AL, Eisenberg JM, Pauly MV, Bloom BS, Glick H, et al. Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. New England Journal of Medicine 324: 1362–1365, 1991

    Article  PubMed  CAS  Google Scholar 

  • Hutton J. Economic appraisal of health technology: a review of the current state of the art in EC countries. In Drummond MF (Ed.) Economic appraisal of health technology in the European Community, Oxford University Press, Oxford, New York, Tokyo, 1987

    Google Scholar 

  • Luce BR, Elixhauser A. Standards for socio-economic evaluation of health care products and services, Springer-Verlag, Berlin, 1990

    Book  Google Scholar 

  • Schrijvers AJP. The Netherlands introduces some competition into the health services. Journal of the American Medical Association 226: 2215–2217, 1991

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Special Programme for Research and Training in Tropical Diseases, World Health Organization, CH-1211, Geneva-27, Switzerland

    David B. Evans

Authors
  1. David B. Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Evans, D.B. The Changing Healthcare Environment. Pharmacoeconomics 1, 5–7 (1992). https://doi.org/10.2165/00019053-199201010-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199201010-00003

Search

Navigation